2nd International Conference on

Respiratory Disease & Care

Respiratory Care-2021

Theme: Current Challenges and Innovative Therapeutics in Respiratory care

The 2nd International Conference on Respiratory Disease and Care will be held in Dubai, UAE, during December 08-09, 2021. The conference subject for respiratory care 2021 is "Current Challenges and Innovative Therapeutics in Respiratory Care."
Keynote speeches, plenary talks, video presentations, seminars, exhibitions, and poster presentations are all part of respiratory disease and care 2021.
This Respiratory care conference is the best platform that would help the pulmonologists and respiratory care professionals to get the insights and latest trends to improve the patients care. All the researchers working in the field of pulmonology, respiratory medicine, asthma, covid-19, pneumonia, emphysema, tuberculosis, COPD, lung diseases, lung cancer, complicated chest infections, and other allied fields will be of interest.

Session 01: COVID-19
Coronavirus can infect the upper or lower part of the breathing tract. It travels down within the airways. the liner can become irritated and inflamed. In some cases, the contamination can reach the whole manner down into alveoli. COVID-19 may be a fresh condition, and scientists are learning greater every day about what it can do to the lungs. They agree that the consequences on the frame are almost like those of two other coronavirus diseases, excessive acute respiratory syndrome (SARS) and Middle East breathing syndrome (MERS).
Respiratory Care Conferences | International Respiratory Care Conferences | Respiratory Conferences | Respiratory Meetings | Respiratory Congress | National Respiratory Conferences 
Session 02: Asthma
The coronavirus disorder (COVID-19) pandemic is horrifying for all citizenry, except for those with asthma, there's the terrific worry that they will have a worse outcome or be far more likely to urge SARS-CoV-2. It’s vital to understand that currently there is no proof of increased infection prices in those with asthma. And albeit the Centers for Disease Control and Prevention states those patients with moderate-severe asthma are often at a greater hazard for the more excessive disorder, there are not any published facts to assist this willpower at this point.
Pulmonology conferences |Respiratory conference |National respiratory conferences |Respiratory congress
Session 03: COPD
The most common are emphysema and chronic bronchitis.There’s no single test for COPD. Diagnosis is based on symptoms, a physical exam, and diagnostic test results. Treatment can ease symptoms, prevent complications, and generally slow disease progression. Your healthcare team may include a lung specialist (pulmonologist) and physical and respiratory therapists. Medications can reduce symptoms and cut down on flare-ups. It may take some trial and error to find the medication and dosage that works best for you.
Lung Diseases Conferences | Respiratory Disease Conferences | Respiratory Disease Webinars | Diseases conferences | Pulmonology Conferences | Respiratory Conferences | National Respiratory Conferences
Session 04: Lung Cancer
The level of lung cancers mostly refers to the extent to which the cancer has unfolded within the body. Treatment of lung cancers can involve a mixture of surgery, chemotherapy, centered remedy, immunotherapy, and radiation remedy in addition to more modern experimental methods. The well-known diagnosis of lung most cancers is bad because medical doctors tend not to discover the disease till it is at an advanced stage. Five-year survival is around 54% for early level lung cancer sufferers that have a tumor localized to the lungs, but handiest around 4% in those with advanced, inoperable lung cancer. Smoking cessation is the most crucial measure that can save you the improvement of lung cancer.
Pulmonary Conferences | Pulmonary Congress | Pulmonary Meetings | Pulmonary Webinars | Respiratory Care Conferences | International Respiratory Care Conferences
Session 05: Pneumonia
Pneumonia is typically precipitated by using contamination with viruses or bacteria and less normally via other microorganisms, certain medicinal drugs and conditions which include autoimmune diseases. Risk elements consist of cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, records of smoking, a poor potential to cough such as following a stroke, and a susceptible immune system. Diagnosis is often based on the signs and symptoms and bodily examination. Chest X-ray, blood tests, and lifestyle of the sputum may also help affirm the diagnosis.
Respiratory Summit | Respiratory Symposium | Pulmonary Seminar | Respiratory Care Seminar | Respiratory Congress | Respiratory Care Conferences | International Respiratory Care Conferences
Session 06: Cardio Pulmonary Disorders
The two primary tobacco-associated cardiopulmonary illnesses are Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD). Exposure to tobacco smoke has long been diagnosed as a prominent chance component for Cardiovascular Disease. Similarly minimizing exposure to tobacco smoke is the most effective manner to save you COPD. However, the mechanisms by way of which tobacco toxicants increase the danger of Cardiovascular Disease  and result in the onset of COPD are nonetheless unclear. 
Respiratory Care Conferences | International Respiratory Care Conferences | Respiratory Conferences | Pulmonary Summit | Respiratory Meetings | Pulmonary Conferences
Session 07: Lung Transplantation
Lung harm can regularly be dealt with medicinal drug or with unique breathing devices. But when these measures no longer lung function turns into existence-threatening, physician might suggest a single-lung transplant or a double-lung transplant. Some human beings with coronary artery ailment may want a procedure to restore blood flow to a blocked or narrowed artery in the heart, similarly to a lung transplant. In a few cases, human beings with severe heart and lung situations may want a combined heart-lung transplant.
Pulmonary Congress | Pulmonary Meetings | Pulmonary Webinars | Respiratory Summit | Respiratory Conferences | International Respiratory Care Conferences
Session 08: Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a situation wherein breathing stops involuntarily for quick durations of time at some point of sleep. Normally, air flows smoothly from the mouth and nose into the lungs in any respect times. In Obstructive sleep apnea , the normal flow of air is time and again stopped all through the night. The waft of air stops because airway space within the region of the throat is too narrow. Snoring is characteristic of Obstructive sleep apnea. 
Respiratory Symposium | Pulmonary Seminar | Respiratory Seminar | Respiratory Congress | International Respiratory Care Conferences | Pulmonary Meetings
Session 09: Occupational Lung Diseases
Asbestosis:  Over time, this ends in lung scarring and stiff lung tissue. It’s frequently linked with creation work.
Coal dirt: This is due to inhaling coal dirt. It reasons lung irritation and scarring. This can motive long-lasting lung harm and shortness of breath.
Silicosis: This is a dust observed within the air of mines, foundries, and blasting operations. It can also increase the chance for different lung sicknesses.
Byssinosis: This is due to inhaling dust from hemp, flax, and cotton processing. It is also called Brown Lung Disease. 
Respiratory Care Conferences | International Respiratory Care Conferences | Respiratory Care Conferences | Respiratory Disease Conferences
Session 10: Pulmonary Hypertension 
Each shape of Pulmonary hypertension is different, so it is important for newly-diagnosed sufferers to discover a Pulmonary hypertension expert who can accurately locate what is causing their Pulmonary hypertension and increase a remedy plan that is right for that specific kind of Pulmonary hypertension as quickly as possible. Every individual with pulmonary hypertension is different, and new studies are being conducted every day with the capability to improve the outlook for people dwelling with this disease.
Respiratory Disease Webinars Diseases Conferences | Pulmonary Conferences | Pulmonary Care Congress | Pulmonary Meetings | Pulmonary Webinars | Respiratory Summit | Respiratory Care Symposium
Session 11: Pulmonary Rehabilitation
Pulmonary rehabilitation may be finished in a number of settings, depending on the patient's desires, and might or won't encompass pharmacologic intervention. Pulmonary rehabilitation is typically precise to the character patient, with the objective of meeting the wishes of the affected person. It is a broad program and may benefit sufferers with lung diseases such as chronic obstructive pulmonary sickness (COPD), sarcoidosis, idiopathic pulmonary fibrosis (IPF) and cystic fibrosis, among others. 
Respiratory Care Conferences | International Respiratory Care Conferences | Respiratory Conferences | Respiratory Meetings | Respiratory Congress | National Respiratory Conferences
Session 12: Tuberculosis
It was historically known as "consumption" due to the burden loss. Active contamination happens more often in people with HIV/AIDS and in those who smoke. Diagnosis of energetic Tuberculosis is primarily based on chest X-rays, in addition to microscopic exam and tradition of frame fluids. Prevention of Tuberculosis includes screening the ones at high danger, early detection and treatment of cases, and vaccination with the bacillus Calmette-Guérin (BCG) vaccine. Treatment requires using multiple antibiotics over a long period of time. Antibiotic resistance is a growing problem with increasing costs of multiple drug-resistant tuberculosis (MDR-TB) and drastically drug-resistant tuberculosis (XDR-TB).
Respiratory SeminarsRespiratory Congress | National Respiratory Conferences | Lung Diseases Conferences | Respiratory Disease ConferencesRespiratory Disease Webinars

The respiratory care devices market is estimated to grow at a CAGR of -12.5 percent from 2020 to 2025, reaching USD 29.9 billion from USD 16.0 billion in 2019. The global pandemic of the corona virus has resulted in a surge in demand for respiratory care devices. The high prevalence of respiratory disorders, the global ageing population, the high prevalence of smoking, rising urbanization and pollution levels, the rising incidence of preterm births, and lifestyle changes are all contributing to the market's rise. 
Scope of Respiratory Care
Because of the expanding prevalence of respiratory ailments, chronic diseases, and the growing geriatric population, therapeutic devices are expected to see healthy growth in the future. CPAP, BiPAP, Humidifiers, Nebulizers, Ventilators, Oxygen Concentrators, and Inhalers are examples of therapeutic devices. These are critical in the recovery of people with respiratory disorders. In the obstructive sleep apnea patient group, CPAP and BiPAP devices are frequently employed. The therapeutic device category is predicted to rise due to the rising number of sleep apnea patients in the United Arab Emirates and the availability of reimbursement coverage in this region.

                                             
COVID-19 Impact on the Global Respiratory Care Devices Market
The COVID-19 outbreak in Wuhan, China, led to the rapid establishment of several hospitals for treating the increasing number of patients. This has been mirrored in other countries as well—Italy and the US also built large hospitals within days to accommodate a growing patient population. In New York, US, the army converted the Javits convention center into a 2,900-bed hospital within four days. Critical care devices are being manufactured in increased quantities to meet growing demand. The state of affairs resulting from the pandemic has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory care devices.
Key Market Players:
The respiratory care devices market is dominated by a few globally established players such as Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US). The study categorizes the respiratory care devices market based on type, indication, end user, component at the regional and global level.
Recent Developments:
In April 2020, Philips launched the PHILIPS RESPIRONICS E30 VENTILATOR. This will enable company to help healthcare professionals by providing superior quality ventilators
In January 2020, Masimo Corporation acquired Connected Care Business from NantHealth (US). This acquisition will support Masimo to assist hospitals in providing constant care through connectivity, automation, and innovative noninvasive monitoring technologies.
In May 2020, Philips did partnership with Masimo. This partnership was aimed at integrating Masimo’s measurement technologies into select intellivue MX-Series multi-parameter monitors to help clinicians examine ventilation status and cerebral oximetry.
In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.
Significant respiratory care associations around the world

Universities and Research institutes in Asia:

Top Universities in Middle East:

Top Universities in Europe:

Top Universities in USA:

Meetings International is announcing Young Scientist Awards through 2nd International conference on Respiratory Disease and Care (Respiratory Care 2021) which is scheduled in Dubai, UAE during December 08-09,2021. This respiratory care conference focuses on “Decoding the myths and facts of organ transplantation”.
Respiratory Care 2021 and  upcoming conferences will recognize participants who have significantly added value to the scientific community of transplantation and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Respiratory Care 2021 focuses mainly on COVID-19 and Respiratory System, Chronic Obstructive Pulmonary Disease and Asthma, Lung Cancer, Pneumonia, Cardio Pulmonary Disorders, Idiopathic Pulmonary Fibrosis, Interstitial, Lung Disease, Lung Transplantation, Obstructive Sleep Apnea, Occupational Lung Diseases, Pulmonary Hypertension and Pulmonary Rehabilitation, Tuberculosis.Transplantation conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.

Eligibility:
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.
Benefits:

  • The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
  • Acknowledgement as YRF Awardee.
  • Promotion on the conference website, Young Researcher Awards and certificates.
  • Link on the conference website.
  • Recognition on Meetings Int. Award Page.
  • Chances to coordinate with partners around the world.
  • Research work can be published in the relevant journal without any publication fee.

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference

Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.
Award Announcements:
Official announcement of the recipients will occur after the completion of Respiratory Care Conference.

International Conference on Respiratory Disease and Care provides liability to all the global emirates to grow your business globally and sell your Research Materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, Instruments.  Breathe life into your products and make moment brand mindfulness with a pennant advertisement arrangement. Make your pennant intuitive to guide individuals to where you need them to go.
Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. 3+ Million Website Visitors, 40000+ Conference Website Visitors and 1000+ Sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally. Meetings International helps you to connect with global clients anywhere at any time via our unrivalled, worldwide professionals reach. Start promoting your brand today, basically browse our immense scope of custom fitted, multi-channel publicizing and sponsorship alternatives across print and computerized stages and select the geology of your intended interest group.
We maintain high quality and ethical standards in event industry, which makes us unique and better than the rest. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
For further queries, connect our conference manager at [email protected]; [email protected]
You can also connect us via WhatsApp: +65 3158 1626

Meetings International has taken an initiative to felicitate attendees with awards to recognize, celebrate and encourage achievement in its various conferences and events. We salute and acknowledge attainment within an industry that is continuously evolving and re-drawing the boundaries of best practice. These awards represent the pinnacle of professional achievement for event professionals. To win an award you will have been endorsed by our illustrious panel of the foremost industry professionals which is a sure-fire signifier of your formidable credentials.



Outstanding Speaker in Respiratory Care 2021: This award recognizes academic and business speakers for their excellent presentation skills and for the significant contribution in Respiratory Care that they make to their professions, their teams and their patients through their practice, leadership or research endeavor. Recipient of this award will be chosen by the session chair and co-chair. The awardees will be felicitated after the completion of oral session.
Our Respiratory Care Conference encourages researchers from across the globe to take part as a speaker at these prestigious events.




Best Key Note Speaker in Respiratory Care 2021: This award recognizes the notable presentations given during the course of the Respiratory Care conference. It also recognizes the enthusiasm and determination of the speaker to improve the experience of all who they come into contact with. The award will be given based on the impact of presentation on the attendees of the event. We will also be taking into account the references taken from the citations of the keynote speaker. These awardees will be felicitated by one of the members of the organizing panel present during the conference.




Best Organizing Committee Member in Respiratory Care 2021: This award seeks to recognize the continuous support provided by the Organizing Committee Member of the conference. Recipient of this award will be selected by the operating committee of the Respiratory Care 2021. The award will be given based on the support and cooperation provided by a member of the organizing panel from the beginning to the successful completion of the conference.

 



Outstanding Masters/Ph.D./Postdoc Thesis work presentation in Respiratory Care 2021: This award seeks to recognize the young brains of the current era. Recipient of this award will be selected by the judge of the Young Researchers Forum. This award will be given based on the presentation skills, impact of research and its applications for the Respiratory Care field. Participants pursuing Masters, PhD or Post-Doctoral studies are eligible for this award. The awardees will be felicitated after the completion of all the oral presentations delivered under the Young Researchers Forum category.



Best Poster Award in Respiratory Care 2021:  This award recognizes the best poster presentation given during the course of an event. Recipient of this award will be selected by the judge of the poster session. An award winning poster will be evaluated on presentation content and clarity, innovativeness of approach, communication criteria and scientific aspects. It will also be based on layout, Respiratory Care science research insights, and analysis and results description. The awardees will be felicitated after the completion of poster session.

The honors are given for our Respiratory Care conferences to perceive the wide scope of obligations and commitment of Respiratory Care and Respiratory Care experts who advance the quickest improvements and inventive practices in the field of Respiratory Care editing and Respiratory Care research. Respiratory Care Events make an immense commitment to surpass the research practices and introduce new insights of Respiratory Care to the globe.

Criteria:
All presented abstracts will automatically be considered for the Award.
All the awards will be selected by the judges of the award category.
The winners will be formally announced during the closing ceremony.
The winners of the Poster Award will receive an award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:
All submissions must be in English.
The topic must fit into scientific sessions of the conference.
Each individual participant is allowed to submit maximum 2 papers.
Abstract must be submitted online as per the given abstract template.
Abstracts must be written in Times New Roman and font size will be 12.
Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.
Each poster should be approximately 1x1 M long. The title, contents, and the author’s information should be clearly visible from a distance of 1-2 feet.

  • COVID-19 and Respiratory System
  • Chronic Obstructive Pulmonary Disease and Asthma
  • Lung Cancer
  • Pneumonia
  • Cardio Pulmonary Disorders
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Lung Transplantation
  • Obstructive Sleep Apnea
  • Occupational Lung Diseases
  • Pulmonary Hypertension and Pulmonary Rehabilitation
  • Tuberculosis

1 Organizing Committee Members

11 Renowned Speakers

Michela Terlizzi

University of Salerno, Italy
Italy

Ourania Kotsiou

University of Thessaly, Greece
Greece

AYUSH PANDEY

SGT University, India
India

T.N. Murthy

NIZAMS INSTITUTE OF MEDICAL SCIENCES, HYDERABAD, INDIA
India

ABDELMALEK MOHAMED ABUSAMRA

Zarqa University, UAE
United Arab Emirates

CHIARA COLARUSSO

University of Salerno, Italy
Italy

Zoya Zabeen

Jamia Hamdard. India
India

Zoya Zabeen

Jamia Hamdard. India
India

NADA SLAMA

Yahia fares University, Medea, Algeria
Algeria

Nightingale Syabbalo

Copperbelt University, Zambia
Zambia

Aloys Tan

Ecosystem Living City Lab, Eindhoven Area
Netherlands

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner